Industry Survey Reveals Clinical Data Management Delays are Slowing Study Completion


Pharmaceutical Executive

A survey recently completed by the industry revealed that the time it takes companies to design and release clinical study databases is having a negative impact on the completion of trials. The delays around the database lead to increased time for other data management processes which ultimately contributes to the slowing of study completion all together. 

Read the full release here.


Related Videos
Jason Tate, FSP Talent Strategy Lead, PPD, part of Thermo Fisher Scientific
Related Content